National Practice Guideline on the Treatment of Localised Prostate Cancer – Part 2

This is a clinical practice guideline for the treatment of localized prostate cancer. The guideline reviews patient information, radical treatment, high intensity focused ultrasound (HIFU) and hormones in mono-therapy. Outcomes of interest include survival (disease-free, overall, distant metastases-free, biochemical disease-free), treatment-related mortality, health related quality of life, and treatment-related adverse effects including impotency, toxicity, obstructive and irritative urinary symptoms and cardiovascular events.